Obesity News and Research

Latest Obesity News and Research

BEE Healthy Kids Fitness Buzz opened at Jefferson Science Magnet Elementary School in Norwalk

Today, U.S. Congressman Jim Himes, Norwalk Mayor Richard Moccia and the GE Hispanic Forum will host the region’s first BEE Healthy Kids Fitness Buzz at Jefferson Science Magnet Elementary School in Norwalk, Connecticut.

30 Jan 2010

Obesity related health complications more dangerous than risks associated with bariatric surgery

Bariatric weight-loss surgery may sound dangerous and complicated, but a Geisinger physician warns that the real danger may be a life of obesity.

30 Jan 2010

Surgeon General's report lays out recommendations to address childhood obesity

"As many as one in three children are overweight or obese, according to a new report" released yesterday by U.S. Surgeon General Regina Benjamin.

30 Jan 2010

Ongoing parenting is necessary to improve children's food choices

Many parents become passive when it comes to their children's food choices. The growing epidemic of obesity in America is a strong indicator of this lapse in parenting. With the variety of resources available from the USDA My Pyramid program to local schools' curriculums, Dr. Sasson ("Dr. Sass") Moulavi, M.D., is surprised by parents' neglect when it comes to allowing poor food choices for children.

29 Jan 2010

Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

Conatus Pharmaceuticals Inc. announced today the initiation of a Phase II clinical trial evaluating CTS-1027 in combination with pegylated interferon (Pegasys®) and ribavirin (Copegus®) in refractory HCV patients. Antiviral activity, safety and tolerability of the triple combination will be assessed after up to 48 weeks of therapy.

28 Jan 2010

Ligand Pharmaceuticals acquires Metabasis Therapeutics

Ligand Pharmaceuticals Incorporated announced that it has completed the acquisition of Metabasis Therapeutics, Inc. (NASDAQ:MBRX), following approval of the transaction by Metabasis stockholders yesterday. As a result, Ligand gains a fully funded partnership with Roche, additional pipeline assets and drug discovery technologies and resources. The transaction was first announced on October 27, 2009.

28 Jan 2010

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

Novella Clinical Inc. (formerly PharmaLinkFHI) and OSI Pharmaceuticals, Inc. announced today that the Companies will expand their existing clinical service agreement. Under the terms of the new agreement, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years as OSI transitions its clinical operations to its new Ardsley, New York campus. Novella will assume use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.

28 Jan 2010

EnteroMedics to submit an IDE application for next-generation Maestro RC System

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company’s EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.

28 Jan 2010

GUMC invites Washington-area residents for Spring 2010 Mini-Medical School Program

Georgetown University Medical Center (GUMC) is inviting Washington-area residents to find out what it takes to become a doctor—minus the long hours and late nights. Georgetown's eight-week Spring 2010 Mini-Medical School Program, open to the public and members of the media, begins Tuesday, March 9, 2010.

28 Jan 2010

Avonworth Middle School commended for its efforts to boost physical activity among students

During a visit today to Avonworth Middle School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to boost physical activity among students.

28 Jan 2010

New study questions current BMI guidelines for older adults

Adults aged over 70 years who are classified as overweight are less likely to die over a ten year period than adults who are in the 'normal' weight range, according to a new study published today in the Journal of The American Geriatrics Society.

28 Jan 2010

New insight into reprogramming of cells

A discovery by Babraham scientists brings new insight into how cells are reprogrammed and a greater understanding of how the environment, or factors like nutritional signals, can interact with our genes to affect health. As an embryo develops, cells acquire a particular fate, for example becoming a nerve or skin cell. The findings, reported online in the journal Nature, pinpoint a protein called AID as being important for complete cellular reprogramming in mammals.

28 Jan 2010

Alli boosts weight loss and reduces excess visceral fat

New studies show that overweight and obese people using alli® (orlistat 60 mg) with a reduced calorie, lower-fat diet can significantly reduce weight, visceral fat, and waist circumference and therefore may reduce their risk of type 2 diabetes, hypertension, heart disease and stroke.

28 Jan 2010

Majority of Americans agree monetary stress can negatively affect health

As we enter a new decade with the hope of rebounding from one of the worst economic downturns in our history, a newly commissioned bank study confirms that nearly 90 percent of Americans agree that monetary stress can negatively affect one’s health. Even more women (91 percent) and older adults (92 percent of those 45 and older) link stress to concerns over money.

28 Jan 2010

GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patients

GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.

28 Jan 2010

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.

28 Jan 2010

Virgin HealthMiles announces significant annual growth in 2009

Virgin HealthMiles, a leading provider of employee health and productivity programs that reward individuals for getting healthy, today announced significant annual growth in 2009, with a 30 percent year-over-year increase in new clients and a 163 percent year-over-year growth in the number of eligible program members.

28 Jan 2010

International congress reflects emerging importance of abdominal obesity

Clinical and basic science researchers from around the world will convene in Hong Kong from January 28 to 30 for the First International Congress on Abdominal Obesity: "Bridging the Gap between Cardiology and Diabetology."

28 Jan 2010

Safe natural extracts reduce hunger and help control appetite

Klaumwell Research Labs, LLC, U.S., a subsidiary of Italian multinational Medestea Internazionale, announced positive results from a double-blind, placebo-controlled clinical study published in the prestigious, peer-reviewed International Journal of Obesity which demonstrates the efficacy of key ingredients contained in a new appetite control spray. Fullfast™ is a clinically tested dietary supplement that helps reduce excessive feelings of hunger.

28 Jan 2010

TE can be accurately performed in majority of NAFLD patients to exclude advanced fibrosis

Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

27 Jan 2010

Obesity News and Research

Latest Obesity News and Research

BEE Healthy Kids Fitness Buzz opened at Jefferson Science Magnet Elementary School in Norwalk

Obesity related health complications more dangerous than risks associated with bariatric surgery

Surgeon General's report lays out recommendations to address childhood obesity

Ongoing parenting is necessary to improve children's food choices

Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV

Ligand Pharmaceuticals acquires Metabasis Therapeutics

Novella Clinical and OSI Pharmaceuticals expand existing clinical service agreement

EnteroMedics to submit an IDE application for next-generation Maestro RC System

GUMC invites Washington-area residents for Spring 2010 Mini-Medical School Program

Avonworth Middle School commended for its efforts to boost physical activity among students

New study questions current BMI guidelines for older adults

New insight into reprogramming of cells

Alli boosts weight loss and reduces excess visceral fat

Majority of Americans agree monetary stress can negatively affect health

GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patients

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Virgin HealthMiles announces significant annual growth in 2009

International congress reflects emerging importance of abdominal obesity

Safe natural extracts reduce hunger and help control appetite

TE can be accurately performed in majority of NAFLD patients to exclude advanced fibrosis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Obesity News and Research

Latest Obesity News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in